Glenn Sblendorio Stock Transactions

On April 27, 2026, Glenn Sblendorio, a director at AMICUS THERAPEUTICS, INC., disposed of 142,564 shares of Common Stock at a price of $14.50 per share. This disposal was part of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. Additionally, Sblendorio had various stock options for Common Stock that were cancelled and converted into cash payments. These options, totaling 281,077 shares, were fully vested at the time of the merger. The cash payment for each option was calculated based on the difference between $14.50 and the option's exercise price.